Discordance between testosterone measurement methods in castrated prostate cancer patients

Discordance between testosterone measurement methods in castrated prostate cancer patients

Failure to suppress testosterone below 0.7 nM in castrated prostate cancer patients is associated with poor clinical outcomes. Testosterone levels in castrated patients are therefore routinely measured. Although mass spectrometry is the gold standard used to measure testosterone, most hospitals use...

Full description

Bibliographic Details
Main Authors: Mélanie Rouleau, Francis Lemire, Michel Déry, Benoît Thériault, Gabriel Dubois, Yves Fradet, Paul Toren, Chantal Guillemette, Louis Lacombe, Laurence Klotz, Fred Saad, Dominique Guérette, Frédéric Pouliot
Format: Article
Language:English
Published: Bioscientifica 2019-02-01
Series:Endocrine Connections
Subjects:
androgen deprivation therapy
immunoassay
mass spectrometry
prostate cancer
testosterone
Online Access:https://ec.bioscientifica.com/view/journals/ec/8/2/EC-18-0476.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/8/2/EC-18-0476.xml

Similar Items